Skip to main content

Table 1 Patient characteristics

From: Changes in serum indoxyl sulfate levels after acute myocardial infarction and the correlation with kidney injury: an observational study

 

(n = 20)

Age (years)

68 ± 12

Sex (male/female)

15/5

Smoking (%)

12 (60)

History of CVD (%)

3 (15)

Diabetes mellitus (%)

12 (60)

Systolic blood pressure (mmHg)

126.9 ± 24.3

Diastolic blood pressure (mmHg)

74.4 ± 15.3

eGFR (mL/min/1.73 m2)

71.6 ± 25.1

Indoxyl sulfate (μg/mL)

0.56 [0.32–0.93]

Max CK (U/L)

1924.0 [719.5–3067.0]

Max CK-MB (U/L)

207.5 [74.3–300.0]

NT-pro BNP (pg/mL)

159.0 [33.3–1610.0]

Dose of contrast media (mL)

190.7 ± 52.5

LVEF (%)

53.1 ± 11.3

Antiplatelet agent (%)

1 (5)

Statin (%)

4 (20)

Ca-blocker (%)

4 (20)

RAS-I (%)

5 (25)

β-blocker (%)

0 (0)

  1. BMI body mass index, CVD cardiovascular disease, eGFR estimated glomerular filtration rate, CK creatine kinase, NT-pro BNP N-terminal pro-B-type natriuretic peptide, LVEF left ventricular ejection fraction, Ca-blocker calcium channel blocker, RAS-I renin-angiotensin system inhibitor